Differential protein adsorption of surface treated Nitinol alloys regulates blood activation K Gegenschatz-Schmid, S Buzzi, J Grossmann, B Roschitzki, D Glück, A Zucker, M Ehrbar Recent research results were presented at the 2019 Annual Meeting of the Swiss Society for Biomaterials + Regenerative Medicine. Abstract: Stents were developed for overcoming heart attacks and strokes caused […]
Qvanteq completed ISO13485:2016 re-certification under the guidance of the notified body DEKRA.
In collaboration with academic institutions, Qvanteq has developed the capability for dynamic testing of any type of cardiovascular device in a blood loop model (Chandler Loop) using fresh whole human blood. This capability is also available for collaborations.
Qvanteq completed ISO13485 re-certification under the guidance of the notified body DEKRA.
Qvanteq AG completed a financing round. It provides the company with sufficient cash to further develop its technology for vascular stents such as intracranial stents and flow diverters.